Gf Fund Management Co. Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 7,818 shares of LXRX stock, worth $9,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,818Holding current value
$9,772% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
128Shares Held
224MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$170 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$48.6 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.52MShares$11.9 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$5.72 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $236M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...